文献速递神经外周血管CT

动脉瘤性蛛网膜下腔出血后早期与延迟期血脑屏障通透性预测延迟性脑缺血及预后

Early and delayed blood-brain barrier permeability predicts delayed cerebral ischemia and outcomes following aneurysmal subarachnoid hemorrhage.
PubMed 文献 · Eur Radiol · 2024-01-15

本研究纳入128例动脉瘤性蛛网膜下腔出血患者,基于延迟性脑缺血(DCI)发生和3个月改良Rankin量表评分分组,比较入院时与DCI时间窗(4-14天)的Ktrans。结果显示DCI组入院Ktrans和DCI时间窗Ktrans均显著高于非DCI组;多因素分析显示入院Ktrans是DCI的独立预测因子,DCI时间窗Ktrans是预后不良的独立预测因子。

要点

  • 入院Ktrans是动脉瘤性蛛网膜下腔出血后延迟性脑缺血的独立预测因子(OR=1.75,95%CI:1.25-2.44,p=0.001)。
  • DCI时间窗(4-14天)Ktrans是3个月预后不良的独立预测因子(OR=1.73,95%CI:1.24-2.43,p=0.001)。
  • 从入院到DCI时间窗连续监测Ktrans可识别可逆与不可逆变化并预测3个月预后。

核心结论

  • 入院时Ktrans升高与延迟性脑缺血的发生相关。
  • 从入院至DCI时间窗连续监测Ktrans可准确识别可逆和不可逆变化,并能预测3个月预后。

研究设计与样本

  • 研究纳入128例动脉瘤性蛛网膜下腔出血患者,按DCI发生情况和3个月改良Rankin量表评分进行分层。
  • 采用CT灌注测量Ktrans,分别于入院时和DCI时间窗(4-14天)进行监测。
  • 采用多因素logistic回归分析识别DCI和预后不良的独立预测因子。

诊断标准与关键数值

  • DCI组入院Ktrans为0.58 ± 0.18,非DCI组为0.47 ± 0.12,组间差异p=0.002。
  • DCI组DCI时间窗Ktrans为0.54 ± 0.19,非DCI组为0.41 ± 0.14,组间差异p<0.001。
  • 预后不良组入院Ktrans为0.53 ± 0.18,预后良好组为0.49 ± 0.14,差异未达统计学显著(p=0.198)。
  • 非DCI组Ktrans从入院时0.47 ± 0.12降至DCI时间窗0.41 ± 0.14(p=0.004);预后良好组从0.49 ± 0.14降至0.41 ± 0.14(p<0.001)。

临床应用与阅片要点

  • CT灌注测量的Ktrans可用于预测动脉瘤性蛛网膜下腔出血后的延迟性脑缺血和3个月预后。
  • 监测从入院至DCI时间窗的Ktrans变化可指导动脉瘤性蛛网膜下腔出血患者的治疗和管理决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to monitor blood-brain barrier permeability within 24 h and during the delayed cerebral ischemia (DCI) time window (DCITW) spanning 4-14 days after aneurysmal subarachnoid hemorrhage (aSAH) and to investigate its correlation with both DCI occurrence and outcomes at three months.

METHODS: A total of 128 patients were stratified based on the DCI occurrence and three-month modified Rankin scale scores. Comparison of Ktrans at admission (admission Ktrans) and during DCITW (DCITW Ktrans) was conducted between DCI and non-DCI groups, as well as between groups with good and poor outcomes. Changes in Ktrans were also analyzed. Multivariate logistic regression analysis was performed to identify independent predictors of DCI and poor outcomes.

RESULTS: Admission Ktrans (0.58 ± 0.18 vs 0.47 ± 0.12, p = 0.002) and DCITW Ktrans (0.54 ± 0.19 vs 0.41 ± 0.14, p < 0.001) were significantly higher in the DCI group compared with the non-DCI group. Although both were higher in the poor outcome group than the good outcome group, the difference was not statistically significant at admission (0.53 ± 0.18 vs 0.49 ± 0.14, p = 0.198). Ktrans in the non-DCI group (0.47 ± 0.12 vs 0.41 ± 0.14, p = 0.004) and good outcome group (0.49 ± 0.14 vs 0.41 ± 0.14, p < 0.001) decreased significantly from the admission to DCITW. Multivariate analysis identified DCITW Ktrans and admission Ktrans as independent predictors of poor outcomes (OR = 1.73, 95%CI: 1.24-2.43, p = 0.001) and DCI (OR = 1.75, 95%CI: 1.25-2.44, p = 0.001), respectively.

CONCLUSION: Elevated Ktrans at admission is associated with the occurrence of DCI. Continuous monitoring of Ktrans from admission to DCITW can accurately identify reversible and irreversible changes and can predict outcomes at 3 months.

CLINICAL RELEVANCE STATEMENT: Ktrans measured with CT perfusion is a valuable tool for predicting both delayed cerebral ischemia and three-month outcomes following aneurysmal subarachnoid hemorrhage. Monitoring changes in Ktrans from admission to time window of delayed cerebral ischemia can guide treatment and management decisions for aneurysmal subarachnoid hemorrhage patients.

KEY POINTS: • Ktrans measured at admission and during the delayed cerebral ischemia time window (4-14 days) holds distinct clinical significance following aneurysmal subarachnoid hemorrhage. • Admission Ktrans serves as a predictor for delayed cerebral ischemia, while continuous assessment of Ktrans from admission to the delayed cerebral ischemia time window can predict three-month outcomes. • Monitoring Ktrans at different stages improves instrumental in enhancing decision-making and treatment planning for patients with aneurysmal subarachnoid hemorrhage.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang C, Tang W, Cheng L, et al. Early and delayed blood-brain barrier permeability predicts delayed cerebral ischemia and outcomes following aneurysmal subarachnoid hemorrhage. Eur Radiol. 2024. PMID: 38221580. doi:10.1007/s00330-023-10571-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。